Bone marrow mesenchymal stem cells promote the repair of islets from diabetic mice through paracrine actions

Molecular and Cellular Endocrinology

Volumn 388, Issue 1-2, 2014, Pages 41-50

  Gao, Xiaodong ^a   Song, Lujun ^a   Shen, Kuntang ^a   Wang, Hongshan ^a   Qian, Mengjia ^a   Niu, Weixin ^a   Qin, Xinyu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cell therapy; Diabetes; Paracrine signaling; Regeneration

Indexed keywords

BETA1 INTEGRIN; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NEUROGENIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STEM CELL ANTIGEN 1; CULTURE MEDIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; CELL SIZE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE ABILITY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL TRANSDIFFERENTIATION; CULTURE MEDIUM; DIABETES MELLITUS, EXPERIMENTAL; MESENCHYMAL STROMA CELL; METABOLISM; PANCREAS ISLET; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DIABETES MELLITUS, EXPERIMENTAL; ISLETS OF LANGERHANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICE, TRANSGENIC; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-AKT; REGENERATION; SIGNAL TRANSDUCTION;

EID: 84897476297     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.03.004     Document Type: Article

References (34)

1. Banerjee M., Kumar A., Bhonde R.R. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem. Biophys. Res. Commun. 2005, 328:318-325.
2. Blandino-Rosano M., Perez-Arana G., Mellado-Gil J.M., et al. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J. Mol. Endocrinol. 2008, 41:35-44.
3. Bonner-Weir S., Taneja M., Weir G.C., et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 2000, 97:7999-8004.
4. Chen, S.S., Jiang, T., Wang, Y., et al., 2013. Activation of double-stranded RNA-dependent protein kinase inhibits proliferation of pancreatic β cells. Biochem. Biophys. Res. Commun. doi:10.1016/j.bbrc.2013.12.051.
5. D'Amour K.A., Bang A.G., Eliazer S., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
6. Dor Y., Brown J., Martinez O.I., et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
7. Duvillié B., Attali M., Aiello V., et al. Label-retaining cells in the rat pancreas: location and differentiation potential in vitro. Diabetes 2003, 52:2035-2042.
8. Furth M.E., Atala A. Stem cell sources to treat diabetes. J. Cell. Biochem. 2009, 106:507-511.
9. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 2005, 11:367-368.
10. Gnecchi M., Zhang Z., Ni A., et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
11. + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
12. Hasegawa Y., Ogihara T., Yamada T., et al. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 2007, 148:2006-2015.
13. Hayes H.L., Moss L.G., Schisler J.C., et al. Pdx-1 activates islet α- and β-cell proliferation via a mechanism regulated by transient receptor potential cation channels 3 and 6 and extracellular signal-regulated kinases 1 and 2. Mol. Cell. Biol. 2013, 33:4017-4029.
14. Hess D., Li L., Martin M., et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat. Biotechnol. 2003, 21:763-770.
15. Inada A., Nienaber C., Katsuta H., et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl. Acad. Sci. USA 2008, 105:19915-19919.
16. Jiang R., Han Z., Zhuo G., et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front. Med. 2011, 5:94-100.
17. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 2004, 94:678-685.
18. Kroon E., Martinson L.A., Kadoya K., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
19. Lee R.H., Seo M.J., Reger R.L., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 2006, 103:17438-17443.
20. Liu Y., Dulchavsky D.S., Gao X., et al. Wound repair by bone marrow stromal cells through growth factor production. J. Surg. Res. 2006, 136:336-341.
21. Madec A.M., Mallone R., Afonso G., et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 2009, 52:1391-1399.
22. Nir T., Melton D.A., Dor Y. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 2007, 117:2553-2561.
23. Park K.S., Kim Y.S., Kim J.H., et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 2010, 89:509-517.
24. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 2004, 95:9-20.
25. Poll D.V., Parekkadan B., Cho C.H., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008, 47:1634-1643.
26. Schrader J., Rennekamp W., Niebergall U., et al. Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-actived protein kinase signaling against cell death. Diabetologia 2007, 50:1243-1247.
27. Si Y.L., Zhao Y.L., Hao H.J., et al. MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res. Rev. 2011, 10:93-103.
28. Si Y., Zhao Y., Hao H., et al. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes 2012, 61:1616-1625.
29. Solar M., Cardalda C., Houbracken I., et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev. Cell 2009, 17:849-860.
30. Tuttle R.L., Gill N.S., Pugh W., et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat. Med. 2001, 7:1133-1137.
31. Wang Q., Li L., Xu E., et al. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 2004, 47:478-487.
32. Watada H. Neurogenin 3 is a key transcription factor for differentiation of the endocrine pancreas. Endocr. J. 2004, 51:255-264.
33. Xu X., D'Hoker J., Stangé G., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
34. Zhao M., Amiel S.A., Ajami S., et al. Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS ONE 2008, 3:e2666.